• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Myomo Inc. (Amendment)

    6/4/24 4:02:07 PM ET
    $MYO
    Industrial Specialties
    Health Care
    Get the next $MYO alert in real time by email
    SC 13G/A 1 p64248sc13ga2.htm AMENDMENT NO. 2

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 2)*

     

     

    Myomo, Inc.
    (Name of Issuer)
     
    Common Stock, par value $0.0001
    (Title of Class of Securities)
     
    62857J102
    (CUSIP Number)
     
    December 31, 2023
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)

     

    x Rule 13d-1(c)

     

    ¨ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

       
     

     

    SCHEDULE 13G

     

    CUSIP No. 62857J102

     

    1

    Names of Reporting Persons

     

    Triple Gate Partners, LP
    2

    Check the appropriate box if a member of a Group (see instructions)

      

    (a)  o
    (b)  x Reporting Person is affiliated with other persons
    3

    Sec Use Only

      

     
    4

    Citizenship or Place of Organization

      

    Delaware

    Number of

    Shares

    Beneficially

    Owned by Each

    Reporting

    Person With: 

    5

    Sole Voting Power

      

    2,825,344
    6

    Shared Voting Power

      

    0
    7

    Sole Dispositive Power

     

    2,825,344
    8

    Shared Dispositive Power

     

    0

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    2,825,344
    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

    o
    11

    Percent of class represented by amount in row (9)

     

    9.81% (see Item 4 below)
    12

    Type of Reporting Person (See Instructions)

     

    PN

     

     Page 2 of 7 
     

     

    CUSIP No. 62857J102

     

    1

    Names of Reporting Persons

     

    Triple Gate Capital, LP
    2

    Check the appropriate box if a member of a Group (see instructions)

     

    (a)  ¨
    (b)  x Reporting Person is affiliated with other persons
    3

    Sec Use Only

     

     
    4

    Citizenship or Place of Organization

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by Each

    Reporting

    Person With: 

    5

    Sole Voting Power

     

    2,825,344 (1)
    6

    Shared Voting Power

     

    0
    7

    Sole Dispositive Power

     

    2,825,344 (1)
    8

    Shared Dispositive Power

     

    0

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    2,825,344 (1)
    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

    o
    11

    Percent of class represented by amount in row (9)

     

    9.81% (see Item 4 below)
    12

    Type of Reporting Person (See Instructions)

     

    PN

     

    (1) Triple Gate Capital, LP holds an indirect beneficial interest in the shares which are directly beneficially owned by Triple Gate Partners, LP.

     

     Page 3 of 7 
     

     

    CUSIP No. 62857J102

     

    1

    Names of Reporting Persons

     

    Triple Gate Capital GP, LLC
    2

    Check the appropriate box if a member of a Group (see instructions)

     

    (a)  ¨
    (b)  x Reporting Person is affiliated with other persons
    3

    Sec Use Only

     

     
    4

    Citizenship or Place of Organization

     

    Delaware

    Number of

    Shares

    Beneficially

    Owned by Each

    Reporting

    Person With:

    5

    Sole Voting Power

     

    2,825,344 (1)
    6

    Shared Voting Power

     

    0
    7

    Sole Dispositive Power

     

    2,825,344 (1)
    8

    Shared Dispositive Power

     

    0

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    2,825,344 (1)
    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

    o
    11

    Percent of class represented by amount in row (9)

     

    9.81% (see Item 4 below)
    12

    Type of Reporting Person (See Instructions)

     

    OO

     

    (1) Triple Gate Capital GP, LLC holds an indirect beneficial interest in the shares which are directly beneficially owned by Triple Gate Partners, LP.

     

     Page 4 of 7 
     

     

    CUSIP No. 62857J102

     

    1

    Names of Reporting Persons

     

    Norbert Gottesman
    2

    Check the appropriate box if a member of a Group (see instructions)

     

    (a)  ¨
    (b)  x Reporting Person is affiliated with other persons
    3

    Sec Use Only

     

     
    4

    Citizenship or Place of Organization

     

    United States

    Number of

    Shares

    Beneficially

    Owned by Each

    Reporting

    Person With:

    5

    Sole Voting Power

     

    2,825,344 (1)
    6

    Shared Voting Power

     

    0
    7

    Sole Dispositive Power

      

    2,825,344 (1)
    8

    Shared Dispositive Power

      

    0

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    2,825,344 (1)
    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

      

    o
    11

    Percent of class represented by amount in row (9)

      

    9.81% (see Item 4 below)
    12

    Type of Reporting Person (See Instructions)

      

    IN

     

    (1) Mr. Gottesman may be deemed to hold an indirect beneficial interest in the shares, which are directly beneficially owned by Triple Gate Partners, LP because he is the manager of Triple Gate Capital GP, LLC which is the general partner of Triple Gate Partners, LP. Mr. Gottesman disclaims any beneficial ownership of the shares of Common Stock covered by this Schedule 13G in which he does not have a pecuniary interest.

     

     Page 5 of 7 
     

     

    This Amendment is filed with respect to the shares of common stock, $0.0001 par value (the “Shares”) of Myomo, Inc. (“Issuer”) beneficially owned by the Reporting Persons as of June 4, 2024 and amends and supplements the Schedule 13G filed on August 10, 2020, as previously amended (collectively, the “Schedule 13G”). Except as set forth herein, the Schedule 13G is unmodified.

     

    The names of the persons filing this statement on this Schedule 13G (collectively, the “Reporting Persons”) are Triple Gate Partners, LP (“Partners”), Triple Gate Capital, LP (“IM”), Triple Gate Capital GP, LLC (“GP”), and Mr. Norbert Gottesman. GP is the general partner of Partners. Mr. Gottesman is the manager of GP.

     

    Item 4. Ownership

     

    Item 4 is amended to add the following:

     

    (a) Amount beneficially owned by all Reporting Persons: 2,825,344 Shares

     

    (b) Percent of Class: 9.81% of outstanding Shares, calculated based on 28,814,637 Shares reported as being outstanding as of May 3, 2024 in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on May 8, 2024.

     

    (c)Number of Shares to which the Reporting Persons have:

     

    (i) Sole power to vote or direct the vote: 2,825,344 Shares

     

    (ii) Shared power to vote or direct the vote: 0 Shares

     

    (iii) Sole power to dispose or to direct the disposition of: 2,825,344 Shares

     

    (iv) Shared power to dispose or direct the disposition of: 0 Shares

     

    Item 10.Certifications.

     

    By signing below, the undersigned certifies to the best of its or his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     Page 6 of 7 
     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated:  June 4, 2024

     

      TRIPLE GATE PARTNERS, LP
      By: Triple Gate Capital GP, LLC, as General Partner
       
        By: /s/ Norbert Gottesman
          Norbert Gottesman, Manager

     

     

      TRIPLE GATE CAPITAL, LP
      By: Triple Gate Management, LLC, as General Partner
       
        By: /s/ Norbert Gottesman
          Norbert Gottesman, Manager

     

     

      TRIPLE GATE CAPITAL GP, LLC
       
        By: /s/ Norbert Gottesman
          Norbert Gottesman, Manager

     

     

      /s/ Norbert Gottesman
      Norbert Gottesman, Individually

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

      

     

    Page 7 of 7

     

     

     

    Get the next $MYO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MYO

    DatePrice TargetRatingAnalyst
    7/31/2024$7.00Buy
    Craig Hallum
    5/20/2024$7.00Buy
    Lake Street
    12/15/2023$6.50Buy
    H.C. Wainwright
    More analyst ratings

    $MYO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk Thomas F bought $55,000 worth of shares (50,000 units at $1.10), increasing direct ownership by 13% to 424,420 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/19/25 7:23:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Chief Executive Officer Gudonis Paul R bought $47,295 worth of shares (50,000 units at $0.95), increasing direct ownership by 4% to 1,259,013 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/18/25 7:51:17 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Chief Medical Officer Kovelman Harry covered exercise/tax liability with 13,054 shares, decreasing direct ownership by 8% to 140,618 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    7/2/25 8:20:13 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Myomo Reports Second Quarter 2025 Financial and Operating Results

    Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025. Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): Revenue was $9.7 million, up 28%; 56% of revenue was from Medicare Part B patients. Reven

    8/11/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo to Report Second Quarter 2025 Financial Results on August 11

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Th

    8/4/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo Provides Highlights of Today's Investor & Analyst Day Event

    Senior executives to provide an in-depth review of the Company's business model and discuss long-range aspirational financial metrics Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company's business model, provide a tour of its new headquarters and manufacturing facility and discuss long-range aspirational financial metrics. A live and archived webcast of the event is available here. To be held

    6/18/25 8:30:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk Thomas F bought $55,000 worth of shares (50,000 units at $1.10), increasing direct ownership by 13% to 424,420 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/19/25 7:23:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Chief Executive Officer Gudonis Paul R bought $47,295 worth of shares (50,000 units at $0.95), increasing direct ownership by 4% to 1,259,013 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    8/18/25 7:51:17 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Director Kirk Thomas F bought $125,993 worth of shares (38,767 units at $3.25), increasing direct ownership by 13% to 344,700 units (SEC Form 4)

    4 - MYOMO, INC. (0001369290) (Issuer)

    5/15/25 4:53:28 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    SEC Filings

    View All

    SEC Form 10-Q filed by Myomo Inc.

    10-Q - MYOMO, INC. (0001369290) (Filer)

    8/11/25 4:15:27 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MYOMO, INC. (0001369290) (Filer)

    8/11/25 4:15:33 PM ET
    $MYO
    Industrial Specialties
    Health Care

    SEC Form 144 filed by Myomo Inc.

    144 - MYOMO, INC. (0001369290) (Subject)

    6/30/25 8:12:58 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on Myomo with a new price target

    Craig Hallum initiated coverage of Myomo with a rating of Buy and set a new price target of $7.00

    7/31/24 7:20:07 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Lake Street initiated coverage on Myomo with a new price target

    Lake Street initiated coverage of Myomo with a rating of Buy and set a new price target of $7.00

    5/20/24 9:00:38 AM ET
    $MYO
    Industrial Specialties
    Health Care

    H.C. Wainwright initiated coverage on Myomo with a new price target

    H.C. Wainwright initiated coverage of Myomo with a rating of Buy and set a new price target of $6.50

    12/15/23 8:26:14 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Myomo Inc.

    SC 13G/A - MYOMO, INC. (0001369290) (Subject)

    10/18/24 2:21:35 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Myomo Inc.

    SC 13G/A - MYOMO, INC. (0001369290) (Subject)

    7/12/24 10:35:49 AM ET
    $MYO
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Myomo Inc.

    SC 13G/A - MYOMO, INC. (0001369290) (Subject)

    7/11/24 6:02:07 PM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Financials

    Live finance-specific insights

    View All

    Myomo Reports Second Quarter 2025 Financial and Operating Results

    Revenue of $9.7 million 816 patients added to the MyoPro pipeline Updates 2025 revenue guidance Conference call begins today at 4:30pm Eastern time Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025. Financial and operating highlights for the second quarter of 2025 include the following (all comparisons are with the second quarter of 2024 unless otherwise indicated): Revenue was $9.7 million, up 28%; 56% of revenue was from Medicare Part B patients. Reven

    8/11/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo to Report Second Quarter 2025 Financial Results on August 11

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Th

    8/4/25 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care

    Myomo Provides Highlights of Today's Investor & Analyst Day Event

    Senior executives to provide an in-depth review of the Company's business model and discuss long-range aspirational financial metrics Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company's business model, provide a tour of its new headquarters and manufacturing facility and discuss long-range aspirational financial metrics. A live and archived webcast of the event is available here. To be held

    6/18/25 8:30:00 AM ET
    $MYO
    Industrial Specialties
    Health Care

    $MYO
    Leadership Updates

    Live Leadership Updates

    View All

    Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mira Kirti Sahney to Inogen's Board of Directors, effective January 31, 2025. The company also announced that Tom West, who has served as a director since April 2023, retired as a member of the Board of Directors, effective January 30, 2025. "We are thrilled to welcome Mira Sahney to the Inogen Board. Mira brings considerable management, technical, and operational experience in the medical device field to Inogen," said Elizabeth Mora, Chairperson of the Board. "Mira's appointment will further strengthen Inogen's Board with a

    2/3/25 4:00:00 PM ET
    $INGN
    $MDT
    $MYO
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus

    Myomo Appoints Heather Getz to its Board of Directors

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A and strategic plannin

    3/28/24 4:05:00 PM ET
    $BFLY
    $MYO
    Medical Electronics
    Health Care
    Industrial Specialties

    Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors. Mr. Jacobovitz, 47, is currently a partner and lead healthcare analyst at AIGH Capital Management and affiliates ("AIGH"), where he has significantly grown AIGH's healthcare footprint since joining in 2014. Prior to AIGH, Mr. Jacobovitz was a managing director at Capstone, a policy research

    1/30/23 4:05:00 PM ET
    $MYO
    Industrial Specialties
    Health Care